.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2014 for a ...
.On the heels of a period 3 succeed that fell short to excite financiers, Ironwood Pharmaceuticals i...
.Don't stop Monte Rosa Rehabs right now. The Boston-based biotech is actually enjoying after authori...
.Welcome to this week's Chutes & Ladders, our summary of considerable leadership hirings, shootin...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has come back to the resource of its antipsychotic powerhouse Vraylar seeking an additional ...
.GenSight Biologics is weeks off of lacking cash. Once more. The biotech only has adequate cash to c...
.Monopar Therapeutics is actually bouncing back a medication from the scrap heap of AstraZeneca's ra...
.Along with new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of analys...
.After developing a genetics therapy relationship with Dyno Rehabs in 2020, Roche is back for more.I...